Annual Accounts Payable
$1.87 M
-$172.00 K-8.44%
December 1, 2023
Summary
- As of February 6, 2025, CSCI annual accounts payable is $1.87 million, with the most recent change of -$172.00 thousand (-8.44%) on December 1, 2023.
- During the last 3 years, CSCI annual accounts payable has risen by +$679.00 thousand (+57.20%).
- CSCI annual accounts payable is now -95.54% below its all-time high of $41.80 million, reached on December 1, 2004.
Performance
CSCI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.40 M
-$1.19 M-33.17%
September 1, 2024
Summary
- As of February 6, 2025, CSCI quarterly accounts payable is $2.40 million, with the most recent change of -$1.19 million (-33.17%) on September 1, 2024.
- CSCI quarterly accounts payable is now -33.17% below its all-time high of $3.58 million, reached on June 1, 2024.
Performance
CSCI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CSCI Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.4% | - |
| 3 y3 years | +57.2% | - |
| 5 y5 years | +45.5% | - |
CSCI Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.4% | +99.8% | -33.2% | at low |
| 5 y | 5-year | -8.4% | +99.8% | -33.2% | at low |
| alltime | all time | -95.5% | +256.2% | -33.2% | +931.9% |
COSCIENS Biopharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.40 M(-33.2%) |
| Jun 2024 | - | $3.58 M(+468.3%) |
| Dec 2023 | $1.87 M(-8.4%) | - |
| Dec 2022 | $2.04 M(+118.2%) | - |
| Dec 2021 | $934.00 K(-21.3%) | - |
| Dec 2020 | $1.19 M(+9.2%) | - |
| Dec 2019 | $1.09 M(-15.2%) | - |
| Dec 2018 | $1.28 M(+4.9%) | - |
| Jun 2018 | - | $630.80 K(-57.2%) |
| Dec 2017 | $1.22 M(-40.2%) | - |
| Dec 2016 | $2.04 M(-17.8%) | - |
| Jun 2016 | - | $1.47 M(+0.6%) |
| Mar 2016 | - | $1.46 M(+1.3%) |
| Dec 2015 | $2.49 M(-21.1%) | $1.45 M(+14.5%) |
| Sep 2015 | - | $1.26 M(+29.6%) |
| Jun 2015 | - | $973.80 K(+4.9%) |
| Mar 2015 | - | $928.30 K(-39.8%) |
| Dec 2014 | $3.15 M(-34.3%) | $1.54 M(+30.9%) |
| Sep 2014 | - | $1.18 M(-29.5%) |
| Jun 2014 | - | $1.67 M(+47.0%) |
| Mar 2014 | - | $1.14 M(+21.8%) |
| Dec 2013 | $4.80 M(-28.0%) | $933.90 K(-9.4%) |
| Sep 2013 | - | $1.03 M(+105.9%) |
| Jun 2013 | - | $500.60 K(-26.5%) |
| Mar 2013 | - | $680.70 K(+17.1%) |
| Dec 2012 | $6.67 M(-17.3%) | $581.20 K(-20.3%) |
| Sep 2012 | - | $729.40 K(+56.6%) |
| Jun 2012 | - | $465.90 K(-29.7%) |
| Dec 2011 | $8.06 M(+26.2%) | $662.40 K(+11.6%) |
| Dec 2010 | $6.39 M(-21.6%) | - |
| Dec 2009 | $8.15 M(-20.5%) | - |
| Dec 2008 | $10.26 M(-36.2%) | - |
| Sep 2008 | - | $593.40 K(+25.6%) |
| Jun 2008 | - | $472.60 K(-27.0%) |
| Mar 2008 | - | $647.70 K(+29.7%) |
| Dec 2007 | $16.08 M(+129.1%) | $499.30 K(+22.6%) |
| Sep 2007 | - | $407.40 K(-51.2%) |
| Jun 2007 | - | $834.20 K(+46.3%) |
| Mar 2007 | - | $570.10 K(+98.0%) |
| Dec 2006 | $7.02 M | $287.90 K(+24.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2006 | - | $232.20 K(-61.6%) |
| Jun 2006 | - | $604.80 K(+49.1%) |
| Mar 2006 | - | $405.50 K(+65.3%) |
| Dec 2005 | $4.00 M(-90.4%) | $245.30 K(-30.2%) |
| Sep 2005 | - | $351.30 K(-37.7%) |
| Jun 2005 | - | $563.60 K(-18.8%) |
| Mar 2005 | - | $694.00 K(+17.0%) |
| Dec 2004 | $41.80 M(+2.1%) | $593.30 K(+34.0%) |
| Sep 2004 | - | $442.90 K(-11.2%) |
| Jun 2004 | - | $498.60 K(+53.3%) |
| Mar 2004 | - | $325.30 K(-2.7%) |
| Dec 2003 | $40.92 M(+51.4%) | $334.40 K(+1.0%) |
| Sep 2003 | - | $331.20 K(-6.0%) |
| Jun 2003 | - | $352.40 K(-16.5%) |
| Mar 2003 | - | $422.00 K(+46.4%) |
| Dec 2002 | $27.03 M(+83.7%) | $288.20 K(-27.1%) |
| Sep 2002 | - | $395.40 K(-25.4%) |
| Jun 2002 | - | $530.00 K(+18.9%) |
| Mar 2002 | - | $445.70 K(+36.0%) |
| Dec 2001 | $14.72 M(+276.6%) | $327.80 K(-9.6%) |
| Sep 2001 | - | $362.80 K(-25.9%) |
| Jun 2001 | - | $489.70 K(-52.4%) |
| Mar 2001 | - | $1.03 M(-12.0%) |
| Dec 2000 | $3.91 M(+646.0%) | $1.17 M(+6.0%) |
| Sep 2000 | - | $1.10 M(+2.1%) |
| Jun 2000 | - | $1.08 M(-7.7%) |
| Mar 2000 | - | $1.17 M(+5.9%) |
| Dec 1999 | $523.90 K(-77.0%) | $1.10 M(+8.2%) |
| Sep 1999 | - | $1.02 M(+0.4%) |
| Jun 1999 | - | $1.02 M(+2.4%) |
| Mar 1999 | - | $994.00 K(+17.6%) |
| Dec 1998 | $2.27 M(+103.4%) | $844.90 K(-0.8%) |
| Sep 1998 | - | $851.60 K(-50.0%) |
| Jun 1998 | - | $1.70 M(+0.7%) |
| Mar 1998 | - | $1.69 M(+5.2%) |
| Dec 1997 | $1.12 M(+39.3%) | $1.61 M(-32.7%) |
| Sep 1997 | - | $2.39 M(+49.9%) |
| Jun 1997 | - | $1.59 M(+69.1%) |
| Mar 1997 | - | $942.10 K |
| Dec 1996 | $802.70 K | - |
FAQ
- What is COSCIENS Biopharma annual accounts payable?
- What is the all time high annual accounts payable for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual accounts payable year-on-year change?
- What is COSCIENS Biopharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for COSCIENS Biopharma?
What is COSCIENS Biopharma annual accounts payable?
The current annual accounts payable of CSCI is $1.87 M
What is the all time high annual accounts payable for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual accounts payable is $41.80 M
What is COSCIENS Biopharma annual accounts payable year-on-year change?
Over the past year, CSCI annual accounts payable has changed by -$172.00 K (-8.44%)
What is COSCIENS Biopharma quarterly accounts payable?
The current quarterly accounts payable of CSCI is $2.40 M
What is the all time high quarterly accounts payable for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly accounts payable is $3.58 M